In vitro effect of interleukin-12 on antigen-specific lymphocyte proliferative responses from persons infected with human immunodeficiency virus type 1

J Infect Dis. 1996 Sep;174(3):483-9. doi: 10.1093/infdis/174.3.483.

Abstract

The relationship between CD4 lymphocyte count and the in vitro effect of interleukin (IL)-12 on lymphocyte proliferative responses to Candida, tetanus toxoid, and streptokinase antigens was studied in peripheral blood mononuclear cells (PBMC from 30 human immunodeficiency virus (HIV)-infected persons and 10 seronegative controls. IL-12 significantly increased proliferative responses to microbial recall antigens of PBMC from HIV-infected persons with >200 CD4 lymphocytes/mm3 but had little effect on PBMC from patients with more advanced disease. The greatest increase was seen in patients with 200-500 CD4 cells/mm3. Results of limiting dilution analysis suggested that the increase in antigen-specific lymphocyte proliferation in the presence of IL-12 was due to an increase in the number of responding cells rather than an increase in the extent of proliferation of a fixed number of responder cells.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigens, Bacterial / immunology
  • CD4 Lymphocyte Count
  • Candida / immunology
  • Cells, Cultured
  • HIV Infections / immunology*
  • HIV-1* / growth & development
  • Humans
  • Interleukin-12 / pharmacology*
  • Leukocytes, Mononuclear / immunology*
  • Lymphocyte Activation*
  • Phytohemagglutinins / immunology
  • Recombinant Proteins / immunology
  • Streptokinase / immunology
  • T-Lymphocytes / immunology*
  • Tetanus Toxoid / immunology

Substances

  • Antigens, Bacterial
  • Phytohemagglutinins
  • Recombinant Proteins
  • Tetanus Toxoid
  • Interleukin-12
  • Streptokinase